Search

Search Constraints

You searched for: Author/Creator Theofilas, Panos

Search Results

1. 0303 Neurobiological Basis of Sleep Disturbances in Tauopathies: Human Wake-Promoting Neurons Degenerate More in Alzheimer's Disease. (12th April 2019)

2. [P4–273]: TAU BURDEN IN OREXINERGIC WAKE‐PROMOTING NEURONS IN ALZHEIMER'S DISEASE IN COMPARISON TO CORTICAL BASAL DEGENERATION AND PROGRESSIVE SUPRANUCLEAR PALSY: A NEUROPATHOLOGICAL IMPLICATION IN SLEEP DISTURBANCES. (1st July 2017)

3. A post‐mortem study of melanin‐concentrating hormone (MCH) neurons in Alzheimer's disease and progressive supranuclear palsy: The complex degeneration pattern of the lateral hypothalamic area. (31st December 2021)

4. Caspase inhibition mitigates tau cleavage and neurotoxicity in iPSC‐induced neurons with the V337M MAPT mutation. (1st February 2022)

5. Caspase inhibition mitigates tau cleavage and neurotoxicity in iPSC‐induced neurons with the V337M MAPT mutation. (December 2021)

6. Caspase‐6‐cleaved tau is relevant in Alzheimer's disease and marginal in four‐repeat tauopathies: Diagnostic and therapeutic implications. (2nd June 2022)

7. Caspase‐6‐cleaved tau is relevant in Alzheimer's disease but not in 4‐repeat tauopathies: Diagnostic and therapeutic implications. (1st February 2022)

8. Caspase‐6‐cleaved tau is relevant in Alzheimer's disease but not in 4‐repeat tauopathies: Diagnostic and therapeutic implications. (December 2021)

9. Caspase‐6‐mediated tau cleavage and pathology in Alzheimer's disease and other tauopathies: Developing topics. (7th December 2020)